NGM Biopharmaceuticals, Inc. ROA 2019-2023 | NGM
Current and historical return on assets (ROA) values for NGM Biopharmaceuticals, Inc. (NGM) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $-0.14B | $0.17B | -68.01% |
| 2023-09-30 | $-0.15B | $0.19B | -61.70% |
| 2023-06-30 | $-0.17B | $0.22B | -60.20% |
| 2023-03-31 | $-0.18B | $0.26B | -57.47% |
| 2022-12-31 | $-0.16B | $0.31B | -48.36% |
| 2022-09-30 | $-0.15B | $0.34B | -42.65% |
| 2022-06-30 | $-0.14B | $0.34B | -35.64% |
| 2022-03-31 | $-0.13B | $0.36B | -31.23% |
| 2021-12-31 | $-0.12B | $0.40B | -28.69% |
| 2021-09-30 | $-0.12B | $0.42B | -30.24% |
| 2021-06-30 | $-0.12B | $0.42B | -32.28% |
| 2021-03-31 | $-0.11B | $0.45B | -30.94% |
| 2020-12-31 | $-0.10B | $0.33B | -30.23% |
| 2020-09-30 | $-0.09B | $0.33B | -25.74% |
| 2020-06-30 | $-0.07B | $0.35B | -19.47% |
| 2020-03-31 | $-0.05B | $0.36B | -14.13% |
| 2019-12-31 | $-0.04B | $0.38B | -12.29% |
| 2019-09-30 | $-0.01B | $0.39B | -4.11% |
| 2019-06-30 | $-0.01B | $0.40B | -4.57% |
| 2019-03-31 | $-0.01B | $0.23B | -4.18% |
| 2018-12-31 | $-0.00B | $0.25B | -1.63% |
